Navigation Links
Prostate cancer screening program leads to bigger fall in death rates than surrounding areas
Date:4/22/2008

Before the programme was introduced, prostate cancer death rates in the Tyrol were similar to the rest of the country, but after the programme was launched the death rate in the Tyrol started falling by an average of 7.3 per cent a year, more than twice the 3.2 per cent observed in the rest of Austria.

The findings also have important implications for age-related prostate cancer deaths, say the researchers, especially as the number of older men is steadily increasing.

Deaths from prostate cancer in the 80 plus age group have been increasing across Austria, but there has been no evidence of this happening in the Tyrol says co-author Professor Boyle from the International Agency for Research on Cancer.

This indicates that the screening programme in the Tyrol is picking up cases of prostate cancer at an earlier stage of the disease, when it can be treated more effectively. This early treatment reduces the risk of the disease coming back later in life and killing the patient when they are older.

The authors conclude that the introduction of free screening has made an important contribution to reducing prostate cancer death rates in the Tyrol, a region where treatment is freely available to all patients with the disease.

But they acknowledge that there is still controversy surrounding some aspects of screening for prostate cancer that need to be resolved.

These include the effectiveness of PSA testing in all cases, whether aggressive treatment alters the outcome in men with advanced stages of the disease and whether testing and treatment seriously impinge quality of life.

Our study shows that when widespread PSA testing was introduced to the Tyrol, and people with the disease received free treatment to cure their prostate cancer, the fall in death rates was significantly higher than in the rest of Austria says Professor Boyle.

This reduction in death rates is most probably due to th
'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Kenya Government Appoints Emergency Health Workers to Permanent Positions 2Health News:Kenya Government Appoints Emergency Health Workers to Permanent Positions 3Health News:Bone Up On Calcium and Vitamin D for a Chance to Win a Family Vacation to Yellowstone National Park 2Health News:Bone Up On Calcium and Vitamin D for a Chance to Win a Family Vacation to Yellowstone National Park 3Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 2Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 3Health News:Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records 4Health News:Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization 2Health News:Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization 3
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 1Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 2Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 3Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 4Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 5Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 6Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 1Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 2MDMA Board Unanimously Opposes Medical Device Tax 5366 1MDMA Board Unanimously Opposes Medical Device Tax 5366 2